At the current growth rate, diabetes threatens to overwhelm global health care systems. The need for innovation and leadership in preventing and managing diabetes has never been more important.
Our comprehensive diabetes menu offers outstanding quality and accuracy, enabling your lab to do more with less and clinicians to better evaluate diabetes treatment options to improve patient care.
Boost your lab’s productivity and efficiency with our VITROS® Diabetes Menu
Traceable to standardized materials and good correlation with other commercial assays.
Decreases the number of calibration events.
Highly specific antibodies and chemistry detection methods.
Optimizes reagent use and decreases waste.
No cuvettes to wash, no probes to clean, no risk of sample or reagent carry-over.
None-to-minimal cross-reactivity and minimal interferences.
Watch: VITROS® A1c Solution
See how we're revolutionizing the way labs help clinicians treat patients
VITROS® A1c solution: A breakthrough design in whole blood testing*
Break free from the complexities of whole blood A1c testing with our novel enzymatic VITROS A1c slides and built-in intelligent technologies so that you can report A1c results confidently while increasing productivity and efficiency.
*Not commercially available in the U.S., product availability subject to local regulatory requirements.
VITROS A1c slides have a multi-layered dry slide design that delivers exceptional performance. Certified by the National Glycohemoglobin Standardization Program (NGSP), it's free from hemoglobin variant interference.*
*Up to HbS ≤ 41%, HbC ≤ 36%, HbD ≤ 41%, HbE ≤ 40%
- Insulin reagent
- C-peptide assay
- BHB
- Glycated serum protein
VITROS® Immunodiagnostic Products Insulin Reagent
The VITROS Insulin assay helps clinicians understand the cause of a patient’s hypoglycemia and differentiate between Type 1 and Type 2 diabetes.
The VITROS Insulin assay antibody is highly specific for insulin detection, with no cross-reactivity to C-peptide or proinsulin.1 Importantly, it has insignificant or no cross-reactivity to insulin analogs commonly used in diabetes treatment.
1Ding, Qian. Performance Comparison of VITROS Immunodiagnostic Products Insulin Assay. Ortho Clinical Diagnostics PR-03149. 2017
Watch: Topics in HbA1c testing
Learn about the importance of HbA1c result standardization and how it is achieved by the National Glycohemoglobin Standardization Program (NGSP) to enable accurate HbA1c test results worldwide.
Presented by Randie R. Little, PhD, NGSP
Network Laboratory Coordinator and Director, Diabetes Diagnostic Laboratory University of Missouri.
VITROS® diabetes assay menu
Assay menu disclaimer:
This document contains information which is targeted to a wide range of audiences and could contain product details or information otherwise not valid or applicable to your country. Please remember to consult your local legal restrictions, regulations, registrations or intended uses in the country of your origin. Product availability may vary from country to country and is subject to varying regulatory requirements. New QuidelOrtho branding may not be available in all markets, subject to country specific regulatory approval. Please confirm with your local commercial team. Some assays not for use in the United States.
